0.3500
-0.0020
(-0.57%)
At close: April 17 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
26,728
27,865
31,323
40,160
Total Liabilities Net Minority Interest
121,215
93,638
159,426
164,151
Total Equity Gross Minority Interest
-94,487
-65,773
-128,103
-123,991
Total Capitalization
-66,191
-45,461
-122,112
-98,835
Common Stock Equity
-94,487
-65,773
-128,103
-123,991
Capital Lease Obligations
4,764
4,768
4,724
5,543
Net Tangible Assets
-96,405
-67,691
-130,021
-125,909
Working Capital
-64,212
-41,079
-116,580
-116,479
Invested Capital
-31,811
-24,981
-106,574
-91,596
Tangible Book Value
-96,405
-67,691
-130,021
-125,909
Total Debt
67,440
45,560
26,253
37,938
Net Debt
60,501
38,666
14,564
17,226
Share Issued
1,317,990.4130
1,175,459
1,068,400
948,400
Ordinary Shares Number
1,317,990.4130
1,175,459
1,068,400
948,400
12/31/2021 - 12/14/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CVM CEL-SCI Corporation
0.2548
-1.05%
DWTX Dogwood Therapeutics, Inc.
4.2700
+14.48%
THTX Theratechnologies Inc.
2.5200
-1.95%
QURE uniQure N.V.
13.00
+38.45%
MURA Mural Oncology plc
2.7000
+11.57%
AGEN Agenus Inc.
2.0800
+26.06%
PSTV Plus Therapeutics, Inc.
0.6586
-1.95%
CDT Conduit Pharmaceuticals Inc.
0.6201
-20.51%
MTVA MetaVia Inc.
0.7390
+0.91%
BCTX BriaCell Therapeutics Corp.
4.2900
-4.24%